MarketCap
Facebook
X
TelegramAnnual report 2025
added 11-17-2025
Twist Bioscience Corporation Total Current Liabilities 2011-2026 | TWST
Annual Total Current Liabilities Twist Bioscience Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 91.4 M | 71 M | 73.3 M | 90.7 M | 63.1 M | 36 M | 30.4 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 91.4 M | 30.4 M | 65.1 M |
Total Current Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
169 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
5.78 M | - | -6.19 % | $ 10.5 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
372 M | $ 36.86 | 8.22 % | $ 397 M |  China |
 |
Biocept
BIOC
|
5.51 M | - | -13.05 % | $ 7.29 M | USA |
 |
Accelerate Diagnostics
AXDX
|
66.6 M | - | -61.36 % | $ 2.46 M | USA |
 |
BioNano Genomics
BNGO
|
37.3 M | $ 1.27 | -2.44 % | $ 1.61 M | USA |
 |
Castle Biosciences
CSTL
|
49.4 M | $ 39.57 | 0.46 % | $ 1.1 B | USA |
 |
Check-Cap Ltd.
CHEK
|
1.81 M | - | - | $ 9.42 M |  Israel |
 |
Oxford Immunotec Global PLC
OXFD
|
13.8 M | - | - | $ 562 M |  Britain |
 |
Chembio Diagnostics
CEMI
|
39.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
Co-Diagnostics
CODX
|
5.75 M | - | - | $ 79.8 M | USA |
 |
Danaher Corporation
DHR
|
6.8 B | $ 222.4 | 1.61 % | $ 163 B | USA |
 |
Exact Sciences Corporation
EXAS
|
732 M | $ 102.5 | 0.15 % | $ 19 B | USA |
 |
DermTech
DMTK
|
13.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
Global Cord Blood Corporation
CO
|
647 M | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
54.2 M | - | 1.08 % | $ 308 M | USA |
 |
NeoGenomics
NEO
|
301 M | $ 12.27 | 1.74 % | $ 1.55 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.27 B | - | - | $ 10.7 B | USA |
 |
DexCom
DXCM
|
1.56 B | $ 72.9 | -0.19 % | $ 28.1 B | USA |
 |
Guardant Health
GH
|
226 M | $ 114.98 | 0.82 % | $ 14.1 B | USA |
 |
CareDx, Inc
CDNA
|
78.1 M | $ 20.57 | 0.1 % | $ 1.11 B | USA |
 |
Celcuity
CELC
|
31.7 M | $ 111.71 | 2.09 % | $ 4.41 B | USA |
 |
DarioHealth Corp.
DRIO
|
12.5 M | $ 10.74 | 7.19 % | $ 305 M | Israel |
 |
Enzo Biochem
ENZ
|
24.8 M | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
72.9 M | $ 26.07 | -0.52 % | $ 788 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
8.27 M | - | -20.0 % | $ 1.06 M | USA |
 |
Heska Corporation
HSKA
|
39.6 M | - | - | $ 1.31 B | USA |
 |
Lantheus Holdings
LNTH
|
241 M | $ 67.08 | 0.24 % | $ 4.64 B | USA |
 |
IDEXX Laboratories
IDXX
|
1.07 B | $ 632.05 | -5.73 % | $ 52.1 B | USA |
 |
Medpace Holdings
MEDP
|
1.1 B | $ 583.24 | 0.13 % | $ 18.1 B | USA |
 |
Illumina
ILMN
|
1.55 B | $ 140.82 | -2.76 % | $ 22.4 B | USA |
 |
QIAGEN N.V.
QGEN
|
544 M | - | - | $ 10.6 B |  Niderland |
 |
IQVIA Holdings
IQV
|
6.96 B | $ 230.28 | 0.06 % | $ 41.7 B | USA |
 |
National Research Corporation
NRC
|
36.2 M | $ 21.96 | 7.96 % | $ 539 M | USA |
 |
Charles River Laboratories International
CRL
|
994 M | $ 211.81 | 0.58 % | $ 10.9 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
2.17 B | $ 183.76 | -1.72 % | $ 20.4 B | USA |
|
Biodesix
BDSX
|
14.3 M | $ 10.48 | 3.05 % | $ 1.36 B | USA |
 |
Precipio
PRPO
|
3.14 M | $ 24.75 | 0.9 % | $ 32.1 M | USA |
 |
Personalis
PSNL
|
31.1 M | $ 9.39 | 0.21 % | $ 556 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
3.33 B | $ 268.54 | -1.1 % | $ 22.5 B | USA |
 |
ICON Public Limited Company
ICLR
|
2.8 B | $ 175.67 | -2.54 % | $ 14.5 B |  Irlanda |
 |
Agilent Technologies
A
|
1.71 B | $ 135.01 | 0.85 % | $ 41 B | USA |
 |
Biomerica
BMRA
|
1.74 M | $ 2.38 | 0.42 % | $ 5.47 M | USA |
 |
OpGen
OPGN
|
634 K | - | -16.95 % | $ 1.54 M | USA |
 |
Bioventus
BVS
|
175 M | $ 8.26 | 4.1 % | $ 517 M | USA |